NewsThe US approves emergency use of plasma therapy on...

The US approves emergency use of plasma therapy on COVID-19 patients

-

The US Food and Drug Administration (FDA) has allowed the emergency application of plasma therapy on severely ill coronavirus patients in the US, Trump also announced.

The convalescent plasma therapy, also known as plasma therapy is an experimental treatment which is thought to have a positive effect on COVID-19 patients.

The therapy uses plasma – a white entity of blood – extracted from already recovered COVID-19 patients which has antibodies of the virus and is then administered into the infected person to boost immunity against the disease.

According to the BBC, so far, the US has already administered the therapy in 70,000 patients only. Meanwhile, in India, the therapy has been widely used in contrast to the US.

Plasma therapy is a century-old treatment to fend off flu long before the vaccine came in the scene and is a ‘go-to-tactics’ whenever a new disease arrived and history says it has been mostly effective, although not in every case, the Associated Press noted.

“This is what I’ve been looking forward to doing for a long time,” the president told reporters on Sunday, shortly after accusing the FDA of delaying the vaccine roll-out citing political reasons.

“I’m pleased to make a truly historic announcement in our battle against the China virus that will save countless lives,” Trump said.

Trump hailed the treatment as a ‘powerful therapy’ and has urged Americans to come forward and donate their plasma if they had recovered from the virus.

“Obviously, they (FDA) are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!” Trup tweeted slamming FDA.

While the therapy is being approved in countries, there are speculations over the treatment’s efficacy. It must be noted, the FDA approval only implies an “emergency use authorization” since it is still an “investigational product.”

The permission to use the therapy, however, comes with a restriction of pathways that the FDA has set. It means patients will be able to obtain the therapy following one of the three pathways designed by the agency, which includes – Single Patient Emergency IND, Expanded access and Clinical trials.

Experts at @US_FDA who have reviewed the totality of data “have concluded that COVID-19 convalescent plasma is safe and shows promising efficacy, thereby meeting the criteria for an emergency use authorization,” said @SteveFDA. pic.twitter.com/0Rzs8e3oC7

— The White House (@WhiteHouse)
August 23, 2020

“It appeared that the product is safe and we’re comfortable with that and we continue to see no concerning safety signals,” director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks was quoted as saying.

“Covid-19 convalescent plasma can be made available on an experimental basis through local production provided that ethical and safety criteria are met for its preparation and use”, WHO said last month.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Swiss unanimously votes for same-sex union referendum

GENEVA — In Switzerland, a controversial same-sex marriage referendum has been resoundingly approved by voters of the conservative, rich Alpine...

New Covid surge overwhelms hospitals in parts of US

WASHINGTON, D.C. — According to one of the country's top health officials, the spike in coronavirus cases in the...

China wants effeminate male celebs to man up

WASHINGTON — Macho men are in and effeminate male performers are out as Beijing expands its crackdown on China's entertainment...

Billie Eilish, BTS to perform at climate change concert

Billie Eilish, BTS, and Elton John, among others, will donate their star power to Global Citizen Live on Saturday...

Google faces off EU in court over record $5.1 billion antitrust fine

This week, Google will face the European Commission in a five-day court hearing, appealing a record $5.1 billion fine...

WHO’s Covax misses 2021 target. What went wrong?

The latest supply forecast for Covax – the programme for sharing COVID-19 vaccines around the world – suggests that accelerating vaccination...

Must read

You might also likeRELATED
Recommended to you